EICHOR
Recruiting studies: Scid
Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →
SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) InjectionPhase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03217617Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifest
Phase 2 · 1 location(s) · Paul Szabolcs · NCT07284641Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency
Phase 1 · 1 location(s) · Great Ormond Street Hospital for Children NHS Foundation Tru · NCT03601286Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT05432310Targeting Real World Usage In Stroke Treatment
Phase N/A · 13 location(s) · Phenox GmbH · NCT07474935The Mechanistic Biology of Primary Immunodeficiency Disorders
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03394053The Experience of Screening for SCID
Phase N/A · 1 location(s) · King's College London · NCT05651113Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019Genetic Basis of Immunodeficiency
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00055172Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple
Phase 1/Phase 2 · 1 location(s) · Natalie Callander · NCT07479979Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03645460Evaluation of Patients With Immune Function Abnormalities
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00128973Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Phase 1/Phase 2 · 4 location(s) · David Williams · NCT03311503Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expr
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05071222
Look up another condition
Patient organization or foundation? You can brand
this page for your community — your logo, your resources, same honest
registry data, kept current daily.
Ask about branding →